Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer

scientific article published on 15 April 2014

Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00428-014-1578-6
P698PubMed publication ID24733561

P50authorChao-Liang WuQ57246206
P2093author name stringYuh-Shyan Tsai
Cheng-Huang Shen
Yeong-Chin Jou
Syue-Yi Chen
Tzong-Shin Tzai
Chen-Li Lai
Chun-Liang Tung
Hsin-Tzu Tsai
Chang-Te Lin
P2860cites workGlobal cancer statisticsQ22241238
Nuclear distribution of prothymosin alpha and parathymosin: evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replicationQ22254303
Prothymosin alpha in human bloodQ24605975
Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathwayQ28581315
Cancer/testis antigens, gametogenesis and cancerQ29616129
Prothymosin α enhances interleukin 2 receptor expression in normal human T-lymphocytesQ34729463
Urothelial tumorigenesis: a tale of divergent pathwaysQ36234720
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.Q36860110
Prothymosin α overexpression contributes to the development of pulmonary emphysemaQ36906886
Immunocytological and preliminary immunohistochemical studies of prothymosin alpha, a human cancer-associated polypeptide, with a well-characterized polyclonal antibodyQ36942477
European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 updateQ37832571
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.Q37859970
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 updateQ37860472
Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinomaQ38011495
Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavageQ39704112
Prothymosin alpha receptors on lymphocytesQ40976451
Prothymosin alpha promotes cell proliferation in NIH3T3 cells.Q42805123
Functional discontinuities in prothymosin alpha caused by caspase cleavage in apoptotic cellsQ42806913
Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific mannerQ43497809
Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokinesQ45864362
Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.Q46445277
FOXP3 and survival in urinary bladder cancer.Q51732343
Prothymosin alpha fragmentation in apoptosis.Q52538048
The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patientsQ62476897
Immunologic unreactivity in bladder cancer patientsQ70339979
Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alphaQ71703742
Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancerQ72968585
Multiple tRNA attachment sites in prothymosin alphaQ77889091
Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parametersQ79258181
Aberrant prothymosin-alpha expression in human bladder cancerQ81765414
Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancerQ82480819
Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinomaQ83655754
Prognostic relevance of prothymosin-alpha expression in human upper urinary tract transitional cell carcinomaQ84399270
P433issue6
P304page(s)717-724
P577publication date2014-04-15
P1433published inVirchows ArchivQ19059548
P1476titleLoss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer
P478volume464

Reverse relations

cites work (P2860)
Q64071017Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB)
Q39567209Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?
Q64061300Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer
Q90003208The multifaceted immune regulation of bladder cancer

Search more.